STRATA Skin Sciences Showcases XTRAC and TheraclearX at TeraCILAD 2025, Reports Early Adoption Momentum in Mexico.
ByAinvest
Tuesday, Dec 9, 2025 8:17 am ET1min read
SSKN--
STRATA Skin Sciences showcased its XTRAC excimer laser and TheraclearX acne therapy system at TeraCILAD 2025. The company reported early adoption momentum in Mexico, with over 12 new recurring TheraclearX accounts expected by year-end 2025. Dermatologists are seeking effective, non-systemic treatment options, and STRATA's technologies are gaining recognition for improving patient outcomes.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet